A carregar...

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein

Vivax malaria is a major cause of morbidity and mortality worldwide, with several million clinical cases per year and 2.5 billion at risk of infection. A vaccine is urgently needed but the most advanced malaria vaccine, VMP001, confers only very low levels of protection against vivax malaria challen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Atcheson, Erwan, Reyes-Sandoval, Arturo
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408485/
https://ncbi.nlm.nih.gov/pubmed/32402755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.03.063
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!